ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Drugs for Schistosomiasis Market Research Report 2026
Published Date: 2026-01-15
|
Report Code: QYRE-Auto-37F412
Home | Market Reports
Global Drugs for Schistosomiasis Market Insights and Forecast to 2028
BUY CHAPTERS

Global Drugs for Schistosomiasis Market Research Report 2026

Code: QYRE-Auto-37F412
Report
2026-01-15
Pages:115
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals

Drugs for Schistosomiasis Market Size

The global Drugs for Schistosomiasis market was valued at US$ 91.32 million in 2025 and is anticipated to reach US$ 118 million by 2032, at a CAGR of 3.8% from 2026 to 2032.

Drugs for Schistosomiasis Market

Drugs for Schistosomiasis Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Drugs for Schistosomiasis competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Schistosomiasis, also known as snail fever and bilharzia, is a disease caused by parasitic flatworms called schistosomes. The urinary tract or the intestines may be infected. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. Those who have been infected a long time may experience liver damage, kidney failure, infertility, or bladder cancer. In children, it may cause poor growth and learning difficulty.
Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma and Taj Pharmaceuticals are the main manufacturers of drugs for Schistosomiasis.
East Africa is the largest region of drugs for Schistosomiasis, whose market share is about 24%,
Followed by West Africa(20%).
This report delivers a comprehensive overview of the global Drugs for Schistosomiasis market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Drugs for Schistosomiasis. The Drugs for Schistosomiasis market size, estimates, and forecasts are provided in terms of sales volume (M Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Drugs for Schistosomiasis market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Drugs for Schistosomiasis manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Drugs for Schistosomiasis Market Report

Report Metric Details
Report Name Drugs for Schistosomiasis Market
Accounted market size in 2025 US$ 91.32 million
Forecasted market size in 2032 US$ 118 million
CAGR 3.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Praziquantel
  • Oxamniquine
  • Other
by Application
  • S. haematobium
  • S. mansoni
  • S. japonicum
  • S. mekongi
  • S. intercalatum
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Drugs for Schistosomiasis manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Drugs for Schistosomiasis sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Drugs for Schistosomiasis Market growing?

Ans: The Drugs for Schistosomiasis Market witnessing a CAGR of 3.8% during the forecast period 2026-2032.

What is the Drugs for Schistosomiasis Market size in 2032?

Ans: The Drugs for Schistosomiasis Market size in 2032 will be US$ 118 million.

Who are the main players in the Drugs for Schistosomiasis Market report?

Ans: The main players in the Drugs for Schistosomiasis Market are Shin Poong, Merck, Bayer, EIPICO, Chandra Bhagat Pharma, Taj Pharmaceuticals

What are the Application segmentation covered in the Drugs for Schistosomiasis Market report?

Ans: The Applications covered in the Drugs for Schistosomiasis Market report are S. haematobium, S. mansoni, S. japonicum, S. mekongi, S. intercalatum

What are the Type segmentation covered in the Drugs for Schistosomiasis Market report?

Ans: The Types covered in the Drugs for Schistosomiasis Market report are Praziquantel, Oxamniquine, Other

1 Drugs for Schistosomiasis Market Overview
1.1 Product Definition
1.2 Drugs for Schistosomiasis by Type
1.2.1 Global Drugs for Schistosomiasis Market Value by Type: 2025 vs 2032
1.2.2 Praziquantel
1.2.3 Oxamniquine
1.2.4 Other
1.3 Drugs for Schistosomiasis by Application
1.3.1 Global Drugs for Schistosomiasis Market Value by Application: 2025 vs 2032
1.3.2 S. haematobium
1.3.3 S. mansoni
1.3.4 S. japonicum
1.3.5 S. mekongi
1.3.6 S. intercalatum
1.4 Global Drugs for Schistosomiasis Market Size Estimates and Forecasts
1.4.1 Global Drugs for Schistosomiasis Revenue 2021–2032
1.4.2 Global Drugs for Schistosomiasis Sales 2021–2032
1.4.3 Global Drugs for Schistosomiasis Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Drugs for Schistosomiasis Market Competition by Manufacturers
2.1 Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2021–2026)
2.2 Global Drugs for Schistosomiasis Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Drugs for Schistosomiasis Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Drugs for Schistosomiasis, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Drugs for Schistosomiasis, Product Types and Applications
2.7 Global Key Manufacturers of Drugs for Schistosomiasis, Date of Entry into the Industry
2.8 Global Drugs for Schistosomiasis Market Competitive Situation and Trends
2.8.1 Global Drugs for Schistosomiasis Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Drugs for Schistosomiasis Players Market Share by Revenue
2.8.3 Global Drugs for Schistosomiasis Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Drugs for Schistosomiasis Market Scenario by Region
3.1 Global Drugs for Schistosomiasis Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Drugs for Schistosomiasis Sales by Region: 2021–2032
3.2.1 Global Drugs for Schistosomiasis Sales by Region: 2021–2026
3.2.2 Global Drugs for Schistosomiasis Sales by Region: 2027–2032
3.3 Global Drugs for Schistosomiasis Revenue by Region: 2021–2032
3.3.1 Global Drugs for Schistosomiasis Revenue by Region: 2021–2026
3.3.2 Global Drugs for Schistosomiasis Revenue by Region: 2027–2032
3.4 North America Drugs for Schistosomiasis Market Facts & Figures by Country
3.4.1 North America Drugs for Schistosomiasis Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Drugs for Schistosomiasis Sales by Country (2021–2032)
3.4.3 North America Drugs for Schistosomiasis Revenue by Country (2021–2032)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Drugs for Schistosomiasis Market Facts & Figures by Country
3.5.1 Europe Drugs for Schistosomiasis Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Drugs for Schistosomiasis Sales by Country (2021–2032)
3.5.3 Europe Drugs for Schistosomiasis Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Drugs for Schistosomiasis Market Facts & Figures by Region
3.6.1 Asia Pacific Drugs for Schistosomiasis Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Drugs for Schistosomiasis Sales by Region (2021–2032)
3.6.3 Asia Pacific Drugs for Schistosomiasis Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Drugs for Schistosomiasis Market Facts & Figures by Country
3.7.1 Latin America Drugs for Schistosomiasis Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Drugs for Schistosomiasis Sales by Country (2021–2032)
3.7.3 Latin America Drugs for Schistosomiasis Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Drugs for Schistosomiasis Market Facts & Figures by Country
3.8.1 Middle East and Africa Drugs for Schistosomiasis Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Drugs for Schistosomiasis Sales by Country (2021–2032)
3.8.3 Middle East and Africa Drugs for Schistosomiasis Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Drugs for Schistosomiasis Sales by Type (2021–2032)
4.1.1 Global Drugs for Schistosomiasis Sales by Type (2021–2026)
4.1.2 Global Drugs for Schistosomiasis Sales by Type (2027–2032)
4.1.3 Global Drugs for Schistosomiasis Sales Market Share by Type (2021–2032)
4.2 Global Drugs for Schistosomiasis Revenue by Type (2021–2032)
4.2.1 Global Drugs for Schistosomiasis Revenue by Type (2021–2026)
4.2.2 Global Drugs for Schistosomiasis Revenue by Type (2027–2032)
4.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Type (2021–2032)
4.3 Global Drugs for Schistosomiasis Price by Type (2021–2032)
5 Segment by Application
5.1 Global Drugs for Schistosomiasis Sales by Application (2021–2032)
5.1.1 Global Drugs for Schistosomiasis Sales by Application (2021–2026)
5.1.2 Global Drugs for Schistosomiasis Sales by Application (2027–2032)
5.1.3 Global Drugs for Schistosomiasis Sales Market Share by Application (2021–2032)
5.2 Global Drugs for Schistosomiasis Revenue by Application (2021–2032)
5.2.1 Global Drugs for Schistosomiasis Revenue by Application (2021–2026)
5.2.2 Global Drugs for Schistosomiasis Revenue by Application (2027–2032)
5.2.3 Global Drugs for Schistosomiasis Revenue Market Share by Application (2021–2032)
5.3 Global Drugs for Schistosomiasis Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Shin Poong
6.1.1 Shin Poong Company Information
6.1.2 Shin Poong Description and Business Overview
6.1.3 Shin Poong Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Shin Poong Drugs for Schistosomiasis Product Portfolio
6.1.5 Shin Poong Recent Developments/Updates
6.2 Merck
6.2.1 Merck Company Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Merck Drugs for Schistosomiasis Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Bayer
6.3.1 Bayer Company Information
6.3.2 Bayer Description and Business Overview
6.3.3 Bayer Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Bayer Drugs for Schistosomiasis Product Portfolio
6.3.5 Bayer Recent Developments/Updates
6.4 EIPICO
6.4.1 EIPICO Company Information
6.4.2 EIPICO Description and Business Overview
6.4.3 EIPICO Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 EIPICO Drugs for Schistosomiasis Product Portfolio
6.4.5 EIPICO Recent Developments/Updates
6.5 Chandra Bhagat Pharma
6.5.1 Chandra Bhagat Pharma Company Information
6.5.2 Chandra Bhagat Pharma Description and Business Overview
6.5.3 Chandra Bhagat Pharma Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Chandra Bhagat Pharma Drugs for Schistosomiasis Product Portfolio
6.5.5 Chandra Bhagat Pharma Recent Developments/Updates
6.6 Taj Pharmaceuticals
6.6.1 Taj Pharmaceuticals Company Information
6.6.2 Taj Pharmaceuticals Description and Business Overview
6.6.3 Taj Pharmaceuticals Drugs for Schistosomiasis Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Taj Pharmaceuticals Drugs for Schistosomiasis Product Portfolio
6.6.5 Taj Pharmaceuticals Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Drugs for Schistosomiasis Industry Chain Analysis
7.2 Drugs for Schistosomiasis Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Drugs for Schistosomiasis Production Mode & Process Analysis
7.4 Drugs for Schistosomiasis Sales and Marketing
7.4.1 Drugs for Schistosomiasis Sales Channels
7.4.2 Drugs for Schistosomiasis Distributors
7.5 Drugs for Schistosomiasis Customer Analysis
8 Drugs for Schistosomiasis Market Dynamics
8.1 Drugs for Schistosomiasis Industry Trends
8.2 Drugs for Schistosomiasis Market Drivers
8.3 Drugs for Schistosomiasis Market Challenges
8.4 Drugs for Schistosomiasis Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Shin Poong
Merck
Bayer
EIPICO
Chandra Bhagat Pharma
Taj Pharmaceuticals
List of Tables
 Table 1. Global Drugs for Schistosomiasis Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Drugs for Schistosomiasis Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Drugs for Schistosomiasis Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Drugs for Schistosomiasis Sales (M Units) of Key Manufacturers (2021–2026)
 Table 5. Global Drugs for Schistosomiasis Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Drugs for Schistosomiasis Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Drugs for Schistosomiasis Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Drugs for Schistosomiasis Average Price (USD/K Units) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Drugs for Schistosomiasis, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Drugs for Schistosomiasis, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Drugs for Schistosomiasis, Product Types and Applications
 Table 12. Global Key Manufacturers of Drugs for Schistosomiasis, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Drugs for Schistosomiasis Companies by Tier (Tier 1, Tier 2, Tier 3), based on Drugs for Schistosomiasis Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Drugs for Schistosomiasis Sales by Region (M Units), 2021–2026
 Table 18. Global Drugs for Schistosomiasis Sales Market Share by Region (2021–2026)
 Table 19. Global Drugs for Schistosomiasis Sales by Region (M Units), 2027–2032
 Table 20. Global Drugs for Schistosomiasis Sales Market Share by Region (2027–2032)
 Table 21. Global Drugs for Schistosomiasis Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Drugs for Schistosomiasis Revenue Market Share by Region (2021–2026)
 Table 23. Global Drugs for Schistosomiasis Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Drugs for Schistosomiasis Revenue Market Share by Region (2027–2032)
 Table 25. North America Drugs for Schistosomiasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Drugs for Schistosomiasis Sales by Country (M Units), 2021–2026
 Table 27. North America Drugs for Schistosomiasis Sales by Country (M Units), 2027–2032
 Table 28. North America Drugs for Schistosomiasis Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Drugs for Schistosomiasis Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Drugs for Schistosomiasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Drugs for Schistosomiasis Sales by Country (M Units), 2021–2026
 Table 32. Europe Drugs for Schistosomiasis Sales by Country (M Units), 2027–2032
 Table 33. Europe Drugs for Schistosomiasis Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Drugs for Schistosomiasis Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Drugs for Schistosomiasis Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Drugs for Schistosomiasis Sales by Region (M Units), 2021–2026
 Table 37. Asia Pacific Drugs for Schistosomiasis Sales by Region (M Units), 2027–2032
 Table 38. Asia Pacific Drugs for Schistosomiasis Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Drugs for Schistosomiasis Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Drugs for Schistosomiasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Drugs for Schistosomiasis Sales by Country (M Units), 2021–2026
 Table 42. Latin America Drugs for Schistosomiasis Sales by Country (M Units), 2027–2032
 Table 43. Latin America Drugs for Schistosomiasis Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Drugs for Schistosomiasis Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Drugs for Schistosomiasis Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Drugs for Schistosomiasis Sales by Country (M Units), 2021–2026
 Table 47. Middle East and Africa Drugs for Schistosomiasis Sales by Country (M Units), 2027–2032
 Table 48. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Drugs for Schistosomiasis Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Drugs for Schistosomiasis Sales (M Units) by Type (2021–2026)
 Table 51. Global Drugs for Schistosomiasis Sales (M Units) by Type (2027–2032)
 Table 52. Global Drugs for Schistosomiasis Sales Market Share by Type (2021–2026)
 Table 53. Global Drugs for Schistosomiasis Sales Market Share by Type (2027–2032)
 Table 54. Global Drugs for Schistosomiasis Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Drugs for Schistosomiasis Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Drugs for Schistosomiasis Revenue Market Share by Type (2021–2026)
 Table 57. Global Drugs for Schistosomiasis Revenue Market Share by Type (2027–2032)
 Table 58. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2021–2026)
 Table 59. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2027–2032)
 Table 60. Global Drugs for Schistosomiasis Sales (M Units) by Application (2021–2026)
 Table 61. Global Drugs for Schistosomiasis Sales (M Units) by Application (2027–2032)
 Table 62. Global Drugs for Schistosomiasis Sales Market Share by Application (2021–2026)
 Table 63. Global Drugs for Schistosomiasis Sales Market Share by Application (2027–2032)
 Table 64. Global Drugs for Schistosomiasis Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Drugs for Schistosomiasis Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Drugs for Schistosomiasis Revenue Market Share by Application (2021–2026)
 Table 67. Global Drugs for Schistosomiasis Revenue Market Share by Application (2027–2032)
 Table 68. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2021–2026)
 Table 69. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2027–2032)
 Table 70. Shin Poong Company Information
 Table 71. Shin Poong Description and Business Overview
 Table 72. Shin Poong Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 73. Shin Poong Drugs for Schistosomiasis Product
 Table 74. Shin Poong Recent Developments/Updates
 Table 75. Merck Company Information
 Table 76. Merck Description and Business Overview
 Table 77. Merck Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 78. Merck Drugs for Schistosomiasis Product
 Table 79. Merck Recent Developments/Updates
 Table 80. Bayer Company Information
 Table 81. Bayer Description and Business Overview
 Table 82. Bayer Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 83. Bayer Drugs for Schistosomiasis Product
 Table 84. Bayer Recent Developments/Updates
 Table 85. EIPICO Company Information
 Table 86. EIPICO Description and Business Overview
 Table 87. EIPICO Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 88. EIPICO Drugs for Schistosomiasis Product
 Table 89. EIPICO Recent Developments/Updates
 Table 90. Chandra Bhagat Pharma Company Information
 Table 91. Chandra Bhagat Pharma Description and Business Overview
 Table 92. Chandra Bhagat Pharma Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 93. Chandra Bhagat Pharma Drugs for Schistosomiasis Product
 Table 94. Chandra Bhagat Pharma Recent Developments/Updates
 Table 95. Taj Pharmaceuticals Company Information
 Table 96. Taj Pharmaceuticals Description and Business Overview
 Table 97. Taj Pharmaceuticals Drugs for Schistosomiasis Sales (M Units), Revenue (US$ Million), Price (USD/K Units), and Gross Margin (2021–2026)
 Table 98. Taj Pharmaceuticals Drugs for Schistosomiasis Product
 Table 99. Taj Pharmaceuticals Recent Developments/Updates
 Table 100. Key Raw Materials Lists
 Table 101. Raw Materials Key Suppliers Lists
 Table 102. Drugs for Schistosomiasis Distributors List
 Table 103. Drugs for Schistosomiasis Customers List
 Table 104. Drugs for Schistosomiasis Market Trends
 Table 105. Drugs for Schistosomiasis Market Drivers
 Table 106. Drugs for Schistosomiasis Market Challenges
 Table 107. Drugs for Schistosomiasis Market Restraints
 Table 108. Research Programs/Design for This Report
 Table 109. Key Data Information from Secondary Sources
 Table 110. Key Data Information from Primary Sources
 Table 111. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Drugs for Schistosomiasis
 Figure 2. Global Drugs for Schistosomiasis Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Drugs for Schistosomiasis Market Share by Type: 2025 & 2032
 Figure 4. Praziquantel Product Picture
 Figure 5. Oxamniquine Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Drugs for Schistosomiasis Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Drugs for Schistosomiasis Market Share by Application: 2025 & 2032
 Figure 9. S. haematobium
 Figure 10. S. mansoni
 Figure 11. S. japonicum
 Figure 12. S. mekongi
 Figure 13. S. intercalatum
 Figure 14. Global Drugs for Schistosomiasis Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global Drugs for Schistosomiasis Market Size (US$ Million), 2021–2032
 Figure 16. Global Drugs for Schistosomiasis Sales (M Units), 2021–2032
 Figure 17. Global Drugs for Schistosomiasis Average Price (USD/K Units), 2021–2032
 Figure 18. Drugs for Schistosomiasis Report Years Considered
 Figure 19. Drugs for Schistosomiasis Sales Share by Manufacturers in 2025
 Figure 20. Global Drugs for Schistosomiasis Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global Drugs for Schistosomiasis Players: Market Share by Revenue in Drugs for Schistosomiasis in 2025
 Figure 22. Drugs for Schistosomiasis Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global Drugs for Schistosomiasis Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America Drugs for Schistosomiasis Sales Market Share by Country (2021–2032)
 Figure 25. North America Drugs for Schistosomiasis Revenue Market Share by Country (2021–2032)
 Figure 26. U.S. Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe Drugs for Schistosomiasis Sales Market Share by Country (2021–2032)
 Figure 29. Europe Drugs for Schistosomiasis Revenue Market Share by Country (2021–2032)
 Figure 30. Germany Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific Drugs for Schistosomiasis Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific Drugs for Schistosomiasis Revenue Market Share by Region (2021–2032)
 Figure 37. China Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Indonesia Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Thailand Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Malaysia Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Philippines Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Latin America Drugs for Schistosomiasis Sales Market Share by Country (2021–2032)
 Figure 48. Latin America Drugs for Schistosomiasis Revenue Market Share by Country (2021–2032)
 Figure 49. Mexico Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Brazil Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Argentina Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Middle East and Africa Drugs for Schistosomiasis Sales Market Share by Country (2021–2032)
 Figure 53. Middle East and Africa Drugs for Schistosomiasis Revenue Market Share by Country (2021–2032)
 Figure 54. Turkey Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Saudi Arabia Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 56. U.A.E Drugs for Schistosomiasis Revenue Growth Rate (US$ Million), 2021–2032
 Figure 57. Global Sales Market Share of Drugs for Schistosomiasis by Type (2021–2032)
 Figure 58. Global Revenue Market Share of Drugs for Schistosomiasis by Type (2021–2032)
 Figure 59. Global Drugs for Schistosomiasis Price (USD/K Units) by Type (2021–2032)
 Figure 60. Global Sales Market Share of Drugs for Schistosomiasis by Application (2021–2032)
 Figure 61. Global Revenue Market Share of Drugs for Schistosomiasis by Application (2021–2032)
 Figure 62. Global Drugs for Schistosomiasis Price (USD/K Units) by Application (2021–2032)
 Figure 63. Drugs for Schistosomiasis Value Chain
 Figure 64. Channels of Distribution (Direct Vs Distribution)
 Figure 65. Bottom-up and Top-down Approaches for This Report
 Figure 66. Data Triangulation
 Figure 67. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

Global Anti helminthic Drugs Market Research Report 2024
Global Heartworm Disease Treatment Market Research Report 2025
Global Amebiasis Treatment Market Insights Forecast to 2030
Global Coccidiosis Treatment Market Research Report 2024
Global Liver Fluke Treatment Market Insights Forecast to 2030
Global Amebiasis Therapeutics Market Insights Forecast to 2030
Global Renal Diseases Drug Market Insights Forecast to 2030
Albendazole Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Viral Gastroenteritis Drugs Market Research Report 2024
Heartworm Treatment Products Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Triclabendazole Market Research Report 2024
Global Amebiasis Drugs Market Insights Forecast to 2030
Global Amebiasis Market Insights Forecast to 2030
Intestinal Ascariasis Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Urinary Tract Infection UTI Market Research Report 2024
Global Animal Internal Parasiticide Market Insights Forecast to 2030
Global Bacterial Enteric Disease Testing Market Research Report 2024
Global End Stage Renal Disease ESRD Treatment Market Research Report 2025
Global Canine Leptospirosis Treatment Market Research Report 2025
Global Typhoid Fever Diagnostic Fluid Market Research Report 2024
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions